Trial Parameters
Brief Summary
This study is a prospective, single center cohort study that primarily registers the clinical characteristics, outcomes, and influencing factors of patients with different types of cardiovascular diseases. Evaluate multiple examination indicators of patients at baseline, 1 year and longer, and follow up on the incidence of major cardiovascular and cerebrovascular adverse events, heart failure readmission, death, and other endpoint events.
Eligibility Criteria
Inclusion Criteria: 1. Coronary heart disease According to coronary angiography and coronary CTA, at least one coronary artery has a degree of stenosis greater than 50%. 2. Hypertension Hypertension is defined as office systolic blood pressure is ≥ 140mmHg and/or the diastolic blood pressure is ≥ 90mmHg without the use of antihypertensive drugs. 3. Heart failure There is a clear history of organic heart disease, clinical symptoms and signs of heart failure, and objective evidence of heart failure. 4. Cardiomyopathy Including defined dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, etc. 5. Able to sign informed consent form. Exclusion Criteria: 1. Age\<18 years old, or\>80 years old. 2. Patients with various malignant tumors. 3. Liver dysfunction (defined as ALT or total bilirubin greater than three times the upper normal limit). 4. Renal insufficiency (defined as blood creatinine exceeding 1.5 times the upper normal limit). 5. Those who have participated